Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapy for uremic hyperlipidemia.

T A Golper

    Nephron
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Treating hyperlipidemia in dialysis patients involves patient-led lifestyle changes and physician-guided interventions. Therapeutic options range from dialysate composition and dialysis modalities to specific medications and drugs to avoid.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Variations in provider practices in remote patient monitoring on peritoneal dialysis in the USA and Canada.

    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2024
    Same author

    Blood pressure targets in hemodialysis patients.

    Kidney international·2008
    Same author

    Downloadable computer models for maintenance but not acute renal replacement therapy.

    Kidney international·2006
    Same author

    A summary of the 2000 update of the NKF-K/DOQI clinical practice guidelines on peritoneal dialysis adequacy.

    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2002
    Same author

    Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy.

    Kidney international·2001
    Same author

    Incremental dialysis.

    Journal of the American Society of Nephrology : JASN·2001
    Same journal

    The Impact of High-Altitude Acclimatization on Frontal Lobe Executive Function: The Mediating Effect of Creatinine.

    Nephron·2026
    Same journal

    Expert Commentary of the Recent International Pediatric Nephrology Association IgA Vasculitis Nephritis Guidelines.

    Nephron·2026
    Same journal

    Acute effects of exercise on the nephron index under different conditions in middle-aged males - a preliminary study.

    Nephron·2026
    Same journal

    Lysozyme-Associated Nephropathy in Myeloid Neoplasms: A Clinicopathological and Mass Spectrometric Study of Two Cases.

    Nephron·2026
    Same journal

    Prevalence of COVID-19 Pneumonia and Clinical Characteristics in Hemodialysis Patients During the SARS-CoV-2 Omicron Pandemic.

    Nephron·2026
    Same journal

    Real-World Outcomes of Patients with Monoclonal Gammopathy of Renal Significance.

    Nephron·2026
    See all related articles

    Area of Science:

    • Nephrology
    • Cardiology
    • Metabolic Disorders

    Background:

    • Hyperlipidemia is a common complication in patients undergoing dialysis.
    • Managing dyslipidemia is crucial for reducing cardiovascular risk in this population.

    Purpose of the Study:

    • To review and organize therapeutic strategies for hyperlipidemia in dialysis patients.
    • To differentiate between patient-driven and physician-driven interventions.

    Main Methods:

    • Literature review of therapeutic options for hyperlipidemia in dialysis patients.
    • Categorization of interventions into lifestyle modifications, dialytic therapies, and pharmacologic approaches.

    Main Results:

    • Patient-centered approaches include weight management, exercise, and dietary adjustments.

    Related Experiment Videos

  • Physician-guided therapies encompass dialysate modifications, dialysis modalities (peritoneal dialysis, hemodialysis, hemofiltration), and pharmacotherapy.
  • Specific medications to avoid and beneficial agents like L-carnitine are identified.

    • Conclusions:

    • A multi-faceted approach combining lifestyle changes, optimized dialysis, and judicious pharmacotherapy is essential.
    • Individualized treatment plans are necessary to effectively manage hyperlipidemia in dialysis patients.